[11 C]Methionine Emerges as a New Biomarker for Tracking Active Myeloma Lesions

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14696
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

ISRN Oncology
2012English

11 Solutions for Active People

Injury Prevention
EnvironmentalPublic HealthOccupational Health
2016English

Azithromycin Decolonization of STEC—a New Risk Emerges

Nature Reviews Nephrology
Nephrology
2012English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Prognostic Significance of Interim 11 C-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amyloid a as a Biomarker for Preeclampsia

Evidence Based Women's Health Journal
2020English

Value of C-11 Methionine Whole Body PET Imaging in the Diagnosis of Skeletal Metastases

The Egyptian Journal Nuclear Medicine
2014English

New HPLC Method for Determination of Cystatin C Biomarker in Human Blood

European Journal of Chemistry
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy